Sale!

GTPBP3 Gene Combined Oxidative Phosphorylation Deficiency Type 23 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The GTPBP3 Gene Combined Oxidative Phosphorylation Deficiency Type 23 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the GTPBP3 gene responsible for mitochondrial disorders. This comprehensive test utilizes Next-Generation Sequencing technology to detect genetic abnormalities affecting oxidative phosphorylation, the crucial energy production process in cells. Patients experiencing unexplained neurological symptoms, developmental delays, or metabolic abnormalities should consider this test. The analysis provides critical information for accurate diagnosis, personalized treatment planning, and genetic counseling. Available for only $500 USD, this test offers valuable insights into rare mitochondrial conditions affecting multiple organ systems. Results are typically available within 3-4 weeks from sample collection.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

GTPBP3 Gene Combined Oxidative Phosphorylation Deficiency Type 23 NGS Genetic DNA Test

Comprehensive Mitochondrial Disorder Genetic Testing

The GTPBP3 Gene Combined Oxidative Phosphorylation Deficiency Type 23 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare mitochondrial disorders. This advanced genetic analysis specifically targets the GTPBP3 gene, which plays a critical role in mitochondrial protein synthesis and energy production. Combined oxidative phosphorylation deficiency type 23 is a severe metabolic condition that disrupts the body’s ability to generate cellular energy, leading to multi-system complications.

What This Test Measures and Detects

This specialized genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the GTPBP3 gene for pathogenic variants. The test specifically identifies:

  • Point mutations in the GTPBP3 gene coding regions
  • Small insertions and deletions affecting gene function
  • Pathogenic variants disrupting mitochondrial tRNA modification
  • Genetic abnormalities impacting oxidative phosphorylation complex assembly
  • Inheritance patterns for genetic counseling purposes

Who Should Consider This Genetic Test

This test is particularly recommended for individuals presenting with symptoms suggestive of mitochondrial disorders, including:

  • Unexplained neurological symptoms such as seizures, ataxia, or developmental regression
  • Progressive muscle weakness and exercise intolerance
  • Metabolic acidosis and lactic acidosis episodes
  • Failure to thrive in infants and children
  • Cardiomyopathy or cardiac conduction abnormalities
  • Hepatic dysfunction and gastrointestinal symptoms
  • Family history of mitochondrial disorders or unexplained infant deaths
  • Developmental delays and intellectual disability

Clinical Benefits of GTPBP3 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out Combined Oxidative Phosphorylation Deficiency Type 23
  • Personalized Treatment: Enables targeted therapeutic interventions based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Prognostic Information: Helps predict disease progression and potential complications
  • Early Intervention: Facilitates timely management strategies to improve outcomes
  • Research Contribution: Advances understanding of rare mitochondrial disorders

Understanding Your Test Results

Our comprehensive genetic counseling team will help you interpret your results:

  • Positive Result: Indicates the presence of pathogenic GTPBP3 gene variants associated with Combined Oxidative Phosphorylation Deficiency Type 23
  • Negative Result: Suggests no detectable mutations in the GTPBP3 gene, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

Test Pricing Information

Test Component Price (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Testing Method: Next-Generation Sequencing (NGS) Technology
  • Specialty: General Physician and Genetics
  • Department: Genetics
  • Disease Category: Metabolic Disorders

Pre-Test Requirements

Before undergoing testing, patients should provide:

  • Complete clinical history relevant to mitochondrial symptoms
  • Participation in genetic counseling session
  • Detailed pedigree chart of family members affected by similar conditions
  • Informed consent for genetic testing

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality testing results nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about mitochondrial disorders affect your quality of life. Our comprehensive GTPBP3 genetic testing provides the answers you need for informed medical decisions. With rapid turnaround times and expert genetic counseling support, we’re committed to helping you understand your genetic health.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward clarity and personalized care.